ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+56.69%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$563M
AUM Growth
+$563M
(+26%)
Cap. Flow
-$7.06M
Cap. Flow
% of AUM
-1.25%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
51
New
12
Increased
13
Reduced
13
Closed
6
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$18.9M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$17.7M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$14.7M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$7.92M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$7.64M |
Top Sells
| 1 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$33.9M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
$23.7M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$16.9M |
| 4 |
RLYP
RELYPSA INC COM
RLYP
|
$11.3M |
| 5 |
Gilead Sciences
GILD
|
$9.05M |
Sector Composition
| 1 | Healthcare | 84.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Sarepta Therapeutics
SRPT
$1.78B
| $84.1M | 14.76% | 1,369,909 -42,281 | -3% | -$2.6M |
|
2
BioMarin Pharmaceuticals
BMRN
$11.2B
| $38.8M | 6.81% | 419,712 -13,260 | -3% | -$1.23M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $35M | 6.15% | 4,257,347 -81,210 | -2% | -$668K |
|
|
TSRO
4
DELISTED
TESARO, Inc.
TSRO
| $27.8M | 4.88% | 277,703 -236,297 | -46% | -$23.7M |
|
5
Amicus Therapeutics
FOLD
$2.34B
| $27.3M | 4.79% | 3,689,857 -8,808 | -0.2% | -$65.2K |
|
|
DERM
6
DELISTED
Dermira, Inc.
DERM
| $27.3M | 4.78% | 805,926 +84,263 | +12% | +$2.85M |
|
|
AGEN
7
Agenus
AGEN
$133M
| $26.7M | 4.68% | 3,715,938 +616,100 | +20% | +$4.42M |
|
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $25.2M | 4.42% | 792,499 +462,999 | +141% | +$14.7M |
|
9
Neurocrine Biosciences
NBIX
$13.8B
| $24.8M | 4.36% | 490,582 -18,748 | -4% | -$949K |
|
|
IMMU
10
DELISTED
Immunomedics Inc
IMMU
| $23.9M | 4.19% | 7,344,177 -1,212,780 | -14% | -$3.94M |
|
11
Bristol-Myers Squibb
BMY
$96B
| $21.6M | 3.78% | 399,875 -45,464 | -10% | -$2.45M |
|
|
GBT
12
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $20M | 3.52% | 869,263 -94,383 | -10% | -$2.18M |
|
|
AERI
13
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $18.9M | 3.31% | +500,000 | New | +$18.9M |
|
|
GWPH
14
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $17.7M | 3.11% | +133,600 | New | +$17.7M |
|
15
Vanda Pharmaceuticals
VNDA
$279M
| $13.8M | 2.42% | 827,693 +118,114 | +17% | +$1.97M |
|
|
NDRM
16
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $12.7M | 2.23% | 686,303 +129,300 | +23% | +$2.39M |
|
|
TLGT
17
DELISTED
Teligent, Inc
TLGT
| $12.4M | 2.18% | 1,637,819 +347,819 | +27% | +$2.64M |
|
|
SRNE
18
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $11.9M | 2.08% | 1,531,273 -124,001 | -7% | -$960K |
|
|
MRTX
19
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $9.84M | 1.73% | 1,488,487 +273,654 | +23% | +$1.81M |
|
|
CASC
20
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $9.2M | 1.61% | 5,611,323 -133,400 | -2% | -$219K |
|
21
Akebia Therapeutics
AKBA
$833M
| $8.55M | 1.5% | 944,579 +322,706 | +52% | +$2.92M |
|
|
22
Agios Pharmaceuticals
AGIO
$2.19B
| $7.92M | 1.39% | +150,000 | New | +$7.92M |
|
|
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.64M | 1.34% | +141,500 | New | +$7.64M |
|
24
Veracyte
VCYT
$2.39B
| $6.99M | 1.23% | 918,556 | – | – |
|
25
BioCryst Pharmaceuticals
BCRX
$1.74B
| $6.08M | 1.07% | +1,379,402 | New | +$6.08M |
|